51. 2019-nCoV/COVID-19 - Approaches to Viral Vaccine Development and Preventive Measures
- Author
-
Muhammad Bilal, Muhammad Shahzad Nazir, Roberto Parra-Saldivar, and Hafiz M.N. Iqbal
- Subjects
2019-ncov ,covid-19 ,respiratory disease ,safety measures ,viral vaccine ,surface proteins ,control precautions ,Microbiology ,QR1-502 - Abstract
The severity assessment of COVID-19 and transmissibility of newly emerged novel-Coronavirus (2019-nCoV) can effectively help and support to quantify the ongoing pandemic risks. Among several epidemiological measures against COVID-19 severity, the case fatality risk (CFR) assessment is an important measure to track record the overall proportion/ratio of the cumulative number of infected patients with the known outcome (confirmed, recovered, or deceased). Considering the ongoing fatality rate, several case-based preventive measures, Coronavirus protein visualization, and approaches to viral vaccine development are discussed herein. The prompt identification of high-risk entities to confront the uncertainty in the risk of death using the approaches highlighted, herein, is of utmost requirement to tackle the current COVID-19 severity. Moreover, the protein visualization available at the viral surface/ body can give further insight into the appropriate vaccine development.
- Published
- 2020
- Full Text
- View/download PDF